Division of Endocrinology and Metabolism, Department of Medicine, 9th Floor, Clinical Sciences Building, University of Alberta, Edmonton, Alberta T6G 2G3, Canada.
Division of Endocrinology and Metabolism, Department of Medicine, 9th Floor, Clinical Sciences Building, University of Alberta, Edmonton, Alberta T6G 2G3, Canada.
Diabetes Res Clin Pract. 2018 Jun;140:81-87. doi: 10.1016/j.diabres.2018.03.025. Epub 2018 Mar 31.
Gestational diabetes (GDM) occurs more often in women from certain ethnic groups and is also associated with fetal macrosomia. In this study, we investigated the ability of a gestational diabetes screening test (GDS), the 2 h 75 g-Oral Glucose Tolerance Test (OGTT), and glycated hemoglobin (HbA1c) in predicting postpartum dysglycemia and fetal macrosomia in women of Caucasian, Filipino, Chinese and South-Asian descent.
848 women diagnosed with carbohydrate intolerance in pregnancy who completed a 2 h 75 g- OGTT within 6 months postpartum, were included in the study. Receiver Operating Characteristic curve analysis was used to test the ability of antepartum GDS, HbA1c and OGTT in predicting postpartum hyperglycemia, type 2 diabetes (T2D) and neonatal macrosomia (birth weight >4000 g).
20.2% had postpartum hyperglycemia while 3.8% had T2D. Those with postpartum dysglycemia were more likely to be non-Caucasian (South-Asian > Filipino > Chinese), have higher antepartum glucose values, require insulin during pregnancy and have cesarean births. Of HbA1c and the antepartum glucose values, a fasting glucose of ≥5.25 mmol/L was predictive of fetal macrosomia in Caucasians. 1 h glucose of ≥11.05 mmol/L was predictive of postpartum hyperglycemia, while 2 h glucose of ≥9.75 mmol/L was predictive of T2D; ethnicity influenced the predictive ability of these tests.
Ethnicity influences the ability of antepartum glucose and HbA1c to predict the risk of macrosomia and postpartum dysglycemia. This information will help detect those most at risk of T2D.
妊娠糖尿病(GDM)在某些族裔的女性中更为常见,并且与胎儿巨大儿有关。在这项研究中,我们调查了妊娠糖尿病筛查试验(GDS)、2 小时 75 克口服葡萄糖耐量试验(OGTT)和糖化血红蛋白(HbA1c)在预测白种人、菲律宾人、中国人和南亚裔女性产后糖代谢异常和胎儿巨大儿的能力。
848 名在产后 6 个月内完成 2 小时 75 克 OGTT 的妊娠期糖不耐受女性被纳入研究。使用受试者工作特征曲线分析测试产前 GDS、HbA1c 和 OGTT 在预测产后高血糖、2 型糖尿病(T2D)和新生儿巨大儿(出生体重>4000g)方面的能力。
20.2%的女性出现产后高血糖,3.8%的女性患有 T2D。患有产后糖代谢异常的女性更可能是非白种人(南亚裔>菲律宾裔>华裔),产前血糖值更高,怀孕期间需要胰岛素治疗,并且进行剖宫产。在 HbA1c 和产前血糖值中,空腹血糖≥5.25mmol/L 可预测白种人胎儿巨大儿。1 小时血糖≥11.05mmol/L 可预测产后高血糖,而 2 小时血糖≥9.75mmol/L 可预测 T2D;种族影响这些测试的预测能力。
种族影响产前血糖和 HbA1c 预测巨大儿和产后糖代谢异常风险的能力。这些信息将有助于检测那些最容易患 T2D 的人。